Comparison of the Effectiveness of Exercise, Dry Needling and Interfascial Block Treatments in the Treatment of Myofascial Pain Syndrome
Eren Başıbüyük
78 participants
Aug 1, 2025
INTERVENTIONAL
Conditions
Summary
This study aimed to compare interfascial block therapy with commonly used exercise therapy and conventional invasive dry needling therapy, and to evaluate its effectiveness and superiority. Another objective of this study was to evaluate and compare the short-term and long-term effectiveness of interfascial block, dry needling, and exercise therapies on pain, disability, and quality of life in patients with myofascial pain syndrome. In this respect, our study is important in terms of its contribution to the literature.
Eligibility
Inclusion Criteria5
- Myofascial pain in the upper trapezius muscle that has lasted for at least 3 months
- VAS score of 4 or higher for the current pain
- Clinically diagnosed with myofascial pain in the trapezius muscle
- Ages 18 to 55
- Patients who can follow verbal instructions and have no cognitive deficits
Exclusion Criteria11
- Having received interventional injections in the neck and shoulder area within the last 3 months
- Having received physical therapy within the last 3 months
- Having received regular nonsteroidal anti-inflammatory and myorelaxant treatment within the last month
- History of surgery on the affected side (neck or shoulder)
- Chronic inflammatory disease
- Acute infection
- History of malignancy
- Coagulation disorders
- Pregnancy
- Liver and kidney pathologies
- Drug allergy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Cervical range of motion and trapezius fascial stretching exercises
Cervical ROM, fascial stretching exercises for the trapezius muscles, and dry needling of the relevant fascia with Hua Long brand 0.25x25 mm disposable sterile steel acupuncture needles under ultrasound guidance.
Cervical range of motion (ROM) and trapezius muscles are treated with fascial stretching exercises and ultrasound-guided interfascial injection of 1 cc of 2% lidocaine + 4 cc of 0.9% saline solution.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07490366